Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Daisuke Imai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4225-8021; OpenAlex author ID A5070530106. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper

Papers 2

  1. IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2019.02.038↗
  2. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer. Co-author DOI 10.1002/cam4.1087↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toru Ikegami · 2 shared papers, 2017–2019 · strength 0.16
  2. Yoshinao Oda · 2 shared papers, 2017–2019 · strength 0.16
  3. Tomoharu Yoshizumi · 2 shared papers, 2017–2019 · strength 0.16
  4. Shinji Itoh · 2 shared papers, 2017–2019 · strength 0.16
  5. Yoshihiko Maehara · 2 shared papers, 2017–2019 · strength 0.16
  6. Norifumi Harimoto · 1 shared paper, 2017 · strength 0.06
  7. Yuji Soejima · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.